Most importantly, don’t leave nutrition and exercise out of the equation. There is a huge difference between a healthy and an unhealthy thin person.

In this weeks episode, our hosts discuss Microneedling with guest aesthetician Caroline Core. They cover topics like differences between devices, pricing, and what to expect when recovering from ...

U nless you’ve been living under a rock, you’ve probably heard the buzz about weight-loss drugs like Ozempic. Some people ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

A new study suggests that popular weight-loss injections like Wegovy and Mounjaro don't deliver the same dramatic results in ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7% on average.

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...